MENU

Best of the International Liver Congress 2015: Focus on Fatty Liver

The LEAN study is the first clinical trial of a glucagon-like peptide-1 (GLP-1) analogue in patients with nonalcoholic steatohepatitis (NASH). The class of drugs is used to treat type 2 diabetes mellitus. Read more.

Tags: , , .
  • Recent UMKC News

    $20 Million Scholarship Article in The Kansas City Star

    KC Scholars partnership also in U.S. News and World Report … Read more

    Geosciences Professor’s Research Cited in New York Times

    Fengpeng Sun co-authored study on California wildfire seasons The 2015 … Read more

    Bloch Faculty Interviewed on NBC Nightly News

    Brent Never teaches about Kansas City’s racial dividing line Never … Read more

    More